A drug used to treat COVID-19 could be linked to mutations in the virus, scientists have said. Molnupiravir works by causing mutations in the virus's genetic information, or genome, many of which kill ...

In a recent study published in Nature, researchers discovered molnupiravir-associated mutational signature in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes. Molnupiravir has ...

A Covid drug hailed as a game-changer may cause the virus to mutate, scientists warned today. Molnupiravir is given to thousands of vulnerable Brits who test positive, such as patients fighting cancer ...

Whichever way you look at it, the Molnupiravir recent scandal stinks in the nostrils of anyone who takes the time to understand the documents made public and the parliamentary and extra-parliamentary ...

A popular antiviral Covid drug used against the disease is driving unexpected mutations in the virus, a leading team of international scientists have warned. Researchers studied a staggering 15 ...

Merck and Ridgeback Biotherapeutics’ antiviral of the moment, molnupiravir, appears likely to become the first oral treatment approved for Covid-19, after interim analysis showed the pill lowered the ...

Molnupiravir (Lagevrio, Merck Sharpe & Dohme) does not reduce frequency of hospital admissions or deaths in vaccinated, high-risk patients with COVID-19 in the community, according to latest results ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The antiviral reduced the risk for severe symptoms of ...